Clinical trial
Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
NCT00390390 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00390390 |
|---|---|
| Title | Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn |
| Official title | A Phase III, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial of 14 Day Treatment With Lansoprazole 15 mg Once a Day in Frequent Heartburn |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heartburn |
| Intervention type | Drug |
| Interventions | Lansoprazole |
| Enrollment | 576 |
| Start date | Jun 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Oct 19, 2006 |
| Last update posted | May 25, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: